Paclitaxel induces apoptosis through the TAK1–JNK activation pathway

Paclitaxel (PTX) has previously been used to treat tumours of various tissue origins, such as lung, breast, ovarian, prostate cancers and leukemia. PTX‐induced apoptosis is associated with p38 mitogen‐activated protein kinase (p38 MAPK), extracellular signal‐regulated kinase (ERK), nuclear factor‐ka...

Full description

Bibliographic Details
Main Authors: Di Yu‐Wei, Zhuo‐sheng Li, Shu‐min Xiong, Ge Huang, Yan‐fei Luo, Tie‐ying Huo, Mao‐hua Zhou, You‐wei Zheng
Format: Article
Language:English
Published: Wiley 2020-08-01
Series:FEBS Open Bio
Subjects:
JNK
Online Access:https://doi.org/10.1002/2211-5463.12917
id doaj-545fdc6a0a3c4ff18f2a999c5136efdb
record_format Article
spelling doaj-545fdc6a0a3c4ff18f2a999c5136efdb2020-11-25T03:44:38ZengWileyFEBS Open Bio2211-54632020-08-011081655166710.1002/2211-5463.12917Paclitaxel induces apoptosis through the TAK1–JNK activation pathwayDi Yu‐Wei0Zhuo‐sheng Li1Shu‐min Xiong2Ge Huang3Yan‐fei Luo4Tie‐ying Huo5Mao‐hua Zhou6You‐wei Zheng7Division of Laboratory Medicine Guangdong Provincial People’s Hospital Guangdong Academy of Medical Sciences Guangzhou ChinaDivision of Laboratory Medicine Guangdong Provincial People’s Hospital Guangdong Academy of Medical Sciences Guangzhou ChinaDivision of Laboratory Medicine Guangdong Provincial People’s Hospital Guangdong Academy of Medical Sciences Guangzhou ChinaDivision of Laboratory Medicine Guangdong Provincial People’s Hospital Guangdong Academy of Medical Sciences Guangzhou ChinaDivision of Laboratory Medicine Guangdong Provincial People’s Hospital Guangdong Academy of Medical Sciences Guangzhou ChinaDivision of Laboratory Medicine Guangdong Provincial People’s Hospital Guangdong Academy of Medical Sciences Guangzhou ChinaDivision of Laboratory Medicine Guangdong Provincial People’s Hospital Guangdong Academy of Medical Sciences Guangzhou ChinaDivision of Laboratory Medicine Guangdong Provincial People’s Hospital Guangdong Academy of Medical Sciences Guangzhou ChinaPaclitaxel (PTX) has previously been used to treat tumours of various tissue origins, such as lung, breast, ovarian, prostate cancers and leukemia. PTX‐induced apoptosis is associated with p38 mitogen‐activated protein kinase (p38 MAPK), extracellular signal‐regulated kinase (ERK), nuclear factor‐kappa B (NF‐κB) and c‐Jun N‐terminal kinase or stress‐activated protein kinase (JNK/ SAPK) pathways. Transforming growth factor‐beta‐activated kinase 1 (TAK1) and TAK1‐binding protein 1 (TAB1) play an important role in cell apoptosis through the p38, ERK, NF‐κB and JNK signal transduction pathways. To investigate the role of TAK1 in PTX‐induced cell apoptosis, we treated HEK293 and 8305C cells with 0–20 µM PTX for 6, 12 or 24 h. To investigate whether TAK1 can cooperate with PTX for cancer treatment, we transfected cells with TAK1, TAB1 or control plasmid and treated them with PTX (3–10 µM) for 9–24 h. Apoptosis rates were analysed by flow cytometry (Annexin V/PI). Endogenous TAK1 and TAB1, caspase‐7 cleavage, poly ADP‐ribose polymerase (PARP) cleavage, Bcl‐xL level, phospho‐p44/42, phospho‐JNK and phospho‐p38 were detected by western blot. We show that in HEK293 and 8305C cells, PTX enhanced the endogenous TAK1/TAB1 level and induced cell apoptosis in a dose‐ and time‐dependent manner. Upon TAK1 overexpression in HEK293 cells treated with PTX, apoptosis rate, JNK phosphorylation and PARP cleavage increased contrary to heat‐shocked or untreated cells. CRISPR editing of the tak1 gene upon PTX treatment resulted in lower phospho‐JNK and PARP cleavage levels than in cells transfected with the control or the TAK1‐ or TAB1 + TAK1‐containing plasmids. TAK1‐K63A could not induce JNK phosphorylation or PARP cleavage. We conclude that PTX induces HEK293 and 8305C cell apoptosis through the TAK1–JNK activation pathway, potentially highlighting TAK1’s role in chemosensitivity.https://doi.org/10.1002/2211-5463.12917apoptosisCRISPRJNKpaclitaxelTAK1
collection DOAJ
language English
format Article
sources DOAJ
author Di Yu‐Wei
Zhuo‐sheng Li
Shu‐min Xiong
Ge Huang
Yan‐fei Luo
Tie‐ying Huo
Mao‐hua Zhou
You‐wei Zheng
spellingShingle Di Yu‐Wei
Zhuo‐sheng Li
Shu‐min Xiong
Ge Huang
Yan‐fei Luo
Tie‐ying Huo
Mao‐hua Zhou
You‐wei Zheng
Paclitaxel induces apoptosis through the TAK1–JNK activation pathway
FEBS Open Bio
apoptosis
CRISPR
JNK
paclitaxel
TAK1
author_facet Di Yu‐Wei
Zhuo‐sheng Li
Shu‐min Xiong
Ge Huang
Yan‐fei Luo
Tie‐ying Huo
Mao‐hua Zhou
You‐wei Zheng
author_sort Di Yu‐Wei
title Paclitaxel induces apoptosis through the TAK1–JNK activation pathway
title_short Paclitaxel induces apoptosis through the TAK1–JNK activation pathway
title_full Paclitaxel induces apoptosis through the TAK1–JNK activation pathway
title_fullStr Paclitaxel induces apoptosis through the TAK1–JNK activation pathway
title_full_unstemmed Paclitaxel induces apoptosis through the TAK1–JNK activation pathway
title_sort paclitaxel induces apoptosis through the tak1–jnk activation pathway
publisher Wiley
series FEBS Open Bio
issn 2211-5463
publishDate 2020-08-01
description Paclitaxel (PTX) has previously been used to treat tumours of various tissue origins, such as lung, breast, ovarian, prostate cancers and leukemia. PTX‐induced apoptosis is associated with p38 mitogen‐activated protein kinase (p38 MAPK), extracellular signal‐regulated kinase (ERK), nuclear factor‐kappa B (NF‐κB) and c‐Jun N‐terminal kinase or stress‐activated protein kinase (JNK/ SAPK) pathways. Transforming growth factor‐beta‐activated kinase 1 (TAK1) and TAK1‐binding protein 1 (TAB1) play an important role in cell apoptosis through the p38, ERK, NF‐κB and JNK signal transduction pathways. To investigate the role of TAK1 in PTX‐induced cell apoptosis, we treated HEK293 and 8305C cells with 0–20 µM PTX for 6, 12 or 24 h. To investigate whether TAK1 can cooperate with PTX for cancer treatment, we transfected cells with TAK1, TAB1 or control plasmid and treated them with PTX (3–10 µM) for 9–24 h. Apoptosis rates were analysed by flow cytometry (Annexin V/PI). Endogenous TAK1 and TAB1, caspase‐7 cleavage, poly ADP‐ribose polymerase (PARP) cleavage, Bcl‐xL level, phospho‐p44/42, phospho‐JNK and phospho‐p38 were detected by western blot. We show that in HEK293 and 8305C cells, PTX enhanced the endogenous TAK1/TAB1 level and induced cell apoptosis in a dose‐ and time‐dependent manner. Upon TAK1 overexpression in HEK293 cells treated with PTX, apoptosis rate, JNK phosphorylation and PARP cleavage increased contrary to heat‐shocked or untreated cells. CRISPR editing of the tak1 gene upon PTX treatment resulted in lower phospho‐JNK and PARP cleavage levels than in cells transfected with the control or the TAK1‐ or TAB1 + TAK1‐containing plasmids. TAK1‐K63A could not induce JNK phosphorylation or PARP cleavage. We conclude that PTX induces HEK293 and 8305C cell apoptosis through the TAK1–JNK activation pathway, potentially highlighting TAK1’s role in chemosensitivity.
topic apoptosis
CRISPR
JNK
paclitaxel
TAK1
url https://doi.org/10.1002/2211-5463.12917
work_keys_str_mv AT diyuwei paclitaxelinducesapoptosisthroughthetak1jnkactivationpathway
AT zhuoshengli paclitaxelinducesapoptosisthroughthetak1jnkactivationpathway
AT shuminxiong paclitaxelinducesapoptosisthroughthetak1jnkactivationpathway
AT gehuang paclitaxelinducesapoptosisthroughthetak1jnkactivationpathway
AT yanfeiluo paclitaxelinducesapoptosisthroughthetak1jnkactivationpathway
AT tieyinghuo paclitaxelinducesapoptosisthroughthetak1jnkactivationpathway
AT maohuazhou paclitaxelinducesapoptosisthroughthetak1jnkactivationpathway
AT youweizheng paclitaxelinducesapoptosisthroughthetak1jnkactivationpathway
_version_ 1724513515123769344